Navigation Links
Queen's University researcher connects cannabis use and sexual dysfunction
Date:2/22/2011

Rany Shamloul's recent review of the medical literature on cannabis use and sexual health has revealed that cannabis use may negatively impact male sexual performance.

"Cannabis is the most widely-used illicit drug globally," says Dr. Shamloul, a postdoctoral fellow in the Department of Pharmacology and Toxicology. "It is also often used by young, sexually active people who are unaware of the hazardous effects it may be having on their sexual health and performance."

Recent animal and in vitro studies have identified new negative connections between cannabis use and sexual dysfunction that may put an end to previous controversy.

While it was previously known that cannabis could affect certain receptors in the brain, it's now believed that these receptors also exist in the penis. Cannabis use may have an antagonizing effect on these receptors in the penis, making it more difficult for a man to achieve and maintain an erection.

"These findings will change the current understanding of the magnitude of the impact of cannabis use on sexual health," says Dr. Shamloul.

Previous studies examining the effects of cannabis use on male sexual function have been limited and many of these studies have produced contradictory results. While some studies have indicated cannabis could have beneficial effects in enhancing erectile function, other studies have found the opposite.

Dr. Shamloul's research will appear in an upcoming issue of the Journal of Sexual Medicine.


'/>"/>

Contact: Christina Archibald
christina.archibald@queensu.ca
613-533-2877
Queen's University
Source:Eurekalert

Page: 1

Related medicine news :

1. ENT and Allergy Associates Welcomes Tamekia L. Wakefield, MD, Further Reinforcing its Pediatric Sinus Expertise and Capabilities in Queens
2. New York Personal Injury Lawyers Concerned About Toyota Accident in Queens
3. 1 person of 1,900 met AHAs definition of ideal heart health, says University of Pittsburgh study
4. Innovative International Healthcare Partnership established at Arizona State University
5. 2010 AAAS Mentor Award goes to Dr. Joseph M. DeSimone of the University of North Carolina at Chapel Hill, and North Carolina State University
6. 2010 AAAS Lifetime Mentor Award goes to Dr. Joel D. Oppenheim of New York University School of Medicine
7. University of Minnesota researchers study the use of computer vision to diagnose mental disorders
8. University leads the way in global mental health development
9. Boston University School of Medicine professor co-authors first book on deaf ethnicity
10. University Hospitals system-approach to stroke care increases the use of tPA therapy by 13.5-fold
11. Stroke medicines still unaffordable for some survivors, according to University of Michigan research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... Experimentation involving human stem cells (HSCs) ... to its potential for revolutionizing human disease treatment. There are multiple HSC platforms ... cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but what ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... TopConsumerReviews.com recently ... Mobility Scooters . , Mobility Scooters give freedom to people who need help ... Still others may be facing a long period of rehabilitation after an illness or ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology: